Salesforce
CRM
227.80
+3.24
+1.44%
Salesforce
US · CRM
#92 by market cap
Listed 1970
227.80
+3.24
+1.44%
Live - 5344 symbols - heartbeat 120s ago
· 2026-10-08 18:19
Pre-market
225.00
+0.20%
After-hours
227.32
-0.21%
Overnight
223.95
-0.27%
- Market cap
- 187.48B
- P/E (TTM)i
- 20.86
- P/Bi
- 4.89
- EPSi
- 7.80
- Div yieldi
- 0.75%
- 52W posi
- 67%
Reader sentiment
Are you bullish or bearish on CRM?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 35 analysts
Buy
Avg price target
280.70 +23.2%
Price target rangecurrent 227.80
Low160.00
Avg280.70
High400.00
Buy 77%
Hold 20%
Sell 3%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Oppenheimer | -- | BUY | 275.00 |
| 2026-09-28 | Goldman Sachs | -- | BUY | 271.00 |
| 2026-09-21 | Jefferies | -- | BUY | 300.00 |
| 2026-09-18 | UBS | -- | HOLD | 260.00 |
| 2026-09-18 | Citi | -- | HOLD | 263.00 |
| 2026-09-18 | Monness | -- | BUY | 266.00 |
| 2026-09-17 | TD Cowen | -- | BUY | 300.00 |
| 2026-09-17 | Cantor Fitzgerald | -- | BUY | 300.00 |
| 2026-09-17 | CCORF | -- | BUY | 300.00 |
| 2026-09-17 | William Blair | -- | BUY | -- |
| 2026-09-17 | Raymond James | -- | BUY | -- |
| 2026-09-17 | BofA Securities | -- | SELL | 160.00 |
| 2026-09-17 | Freedom Capital Markets | -- | BUY | 295.00 |
| 2026-09-17 | Stifel | -- | BUY | 300.00 |
| 2026-09-17 | Needham | -- | BUY | 400.00 |
| 2026-09-17 | Citi | -- | HOLD | 263.00 |
| 2026-09-17 | Guggenheim | -- | BUY | 300.00 |
| 2026-09-17 | Oppenheimer | -- | BUY | 275.00 |
| 2026-09-17 | J.P. Morgan | -- | BUY | 265.00 |
| 2026-09-16 | Mizuho Securities | -- | BUY | 280.00 |
| 2026-09-16 | BTIG | -- | BUY | 300.00 |
| 2026-09-16 | Truist Financial | -- | BUY | -- |
| 2026-09-16 | Stifel | -- | BUY | 275.00 |
| 2026-09-16 | BMO Capital | -- | BUY | 285.00 |
| 2026-09-16 | Barclays | -- | BUY | 276.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
2 3
■ Upgrades■ Downgrades
- 2 upgrades vs 3 downgrades among tracked analyst rating changes.
- Most recent: BofA Securities moved from Buy to Sell on 2026-08-20.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-20 | BofA Securities | BUY → SELL | 160.00 |
| 2026-07-21 | Morgan Stanley | BUY → HOLD | 185.00 |
| 2026-07-08 | KeyBanc | BUY → HOLD | -- |
| 2026-07-01 | Guggenheim | HOLD → BUY | 228.00 |
| 2026-06-18 | Monness | HOLD → BUY | 200.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q2 | 2026-08-26 | After close | ±6.69% | +22.58% (beat) |
| 2027/Q1 | 2026-05-27 | After close | ±8.11% | -0.75% (in line) |
| 2026/Q4 | 2026-02-25 | After close | ±7.80% | +4.03% (in line) |
| 2026/Q3 | 2025-12-03 | After close | ±7.11% | +3.66% (in line) |
| 2026/Q2 | 2025-09-03 | After close | ±7.93% | -4.85% (in line) |
| 2026/Q1 | 2025-05-28 | After close | ±7.27% | -3.30% (in line) |
| 2025/Q4 | 2025-02-26 | After close | ±8.81% | -4.04% (in line) |
| 2025/Q3 | 2024-12-03 | After close | ±7.44% | +10.99% (beat) |
| 2025/Q2 | 2024-08-28 | After close | ±8.14% | -0.73% (in line) |
| 2025/Q1 | 2024-05-29 | After close | ±7.08% | -19.74% (beat) |
| 2024/Q4 | 2024-02-28 | After close | ±7.95% | +3.02% (in line) |
| 2024/Q3 | 2023-11-29 | After close | ±5.46% | +9.36% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 18:19:30 · For reference only, not investment advice and not tailored to your situation.